Hi folks, I’m publishing my blog a day early since I will be out of the office tomorrow.  Here are the top regulatory news stories for this week: Scott Gottlieb, the commissioner of the Food and Drug Administration, announced plans to speed generic versions of treatments that combine a drug and a device: https://www.forbes.com/sites/matthewherper/2017/11/28/fda-boss-aims-to-close-epipen-loophole/#4af7e7fe39f9 According[…]